(1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one

C113H114Br2N22O13 — CID 157177253

IUPAC(1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one
SMILESCC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]4(COc5cccc(n5)CCCCc5ccc(Br)nc5NC3=O)C[C@@H]24)c2ccc(-c3cnc(C)nc3)cc12.CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]4(COc5cccc(n5)CCc5ccc(Br)nc5NC3=O)C[C@@H]24)c2ccc(-c3cnc(C)nc3)cc12.COC1CCC(=O)CC[C@@]23C[C@@H](C(=O)Cc4cccc(C)n4)N(C(=O)Cn4nc(C(C)=O)c5cc(-c6cnc(C)nc6)cc(c54)CCCC1C)[C@@H]2C3
InChIInChI=1S/C41H48N6O5.C37H35BrN8O4.C35H31BrN8O4/c1-24-8-6-10-28-16-29(30-21-42-27(4)43-22-30)17-33-39(26(3)48)45-46(40(28)33)23-38(51)47-34(35(50)18-31-11-7-9-25(2)44-31)19-41(20-37(41)47)15-14-32(49)12-13-36(24)52-5;1-21(47)34-27-14-24(25-17-39-22(2)40-18-25)10-12-28(27)45(44-34)19-33(48)46-29-15-37(16-30(37)46)20-50-32-9-5-8-26(41-32)7-4-3-6-23-11-13-31(38)42-35(23)43-36(29)49;1-19(45)32-25-12-22(23-15-37-20(2)38-16-23)7-10-26(25)43(42-32)17-31(46)44-27-13-35(14-28(35)44)18-48-30-5-3-4-24(39-30)9-6-21-8-11-29(36)40-33(21)41-34(27)47/h7,9,11,16-17,21-22,24,34,36-37H,6,8,10,12-15,18-20,23H2,1-5H3;5,8-14,17-18,29-30H,3-4,6-7,15-16,19-20H2,1-2H3,(H,42,43,49);3-5,7-8,10-12,15-16,27-28H,6,9,13-14,17-18H2,1-2H3,(H,40,41,47)/t24?,34-,36?,37+,41-;29-,30+,37-;27-,28+,35-/m000/s1
InChIKeyAODRLDFKVFNICO-YZCOWMKUSA-N
MW2148.10 g/mol
LogP16.24
Rot. Bonds14

About (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one

(1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one (PubChem CID 157177253) has the molecular formula C113H114Br2N22O13 and a molecular weight of 2148.10 g/mol. Its IUPAC name is (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one.

Molecular Properties

Compound Name(1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one
PubChem CID157177253
Molecular FormulaC113H114Br2N22O13
Molecular Weight2148.10 g/mol
Exact Mass2144.73
IUPAC Name(1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one
SMILESCC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]4(COc5cccc(n5)CCCCc5ccc(Br)nc5NC3=O)C[C@@H]24)c2ccc(-c3cnc(C)nc3)cc12.CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]4(COc5cccc(n5)CCc5ccc(Br)nc5NC3=O)C[C@@H]24)c2ccc(-c3cnc(C)nc3)cc12.COC1CCC(=O)CC[C@@]23C[C@@H](C(=O)Cc4cccc(C)n4)N(C(=O)Cn4nc(C(C)=O)c5cc(-c6cnc(C)nc6)cc(c54)CCCC1C)[C@@H]2C3
InChIInChI=1S/C41H48N6O5.C37H35BrN8O4.C35H31BrN8O4/c1-24-8-6-10-28-16-29(30-21-42-27(4)43-22-30)17-33-39(26(3)48)45-46(40(28)33)23-38(51)47-34(35(50)18-31-11-7-9-25(2)44-31)19-41(20-37(41)47)15-14-32(49)12-13-36(24)52-5;1-21(47)34-27-14-24(25-17-39-22(2)40-18-25)10-12-28(27)45(44-34)19-33(48)46-29-15-37(16-30(37)46)20-50-32-9-5-8-26(41-32)7-4-3-6-23-11-13-31(38)42-35(23)43-36(29)49;1-19(45)32-25-12-22(23-15-37-20(2)38-16-23)7-10-26(25)43(42-32)17-31(46)44-27-13-35(14-28(35)44)18-48-30-5-3-4-24(39-30)9-6-21-8-11-29(36)40-33(21)41-34(27)47/h7,9,11,16-17,21-22,24,34,36-37H,6,8,10,12-15,18-20,23H2,1-5H3;5,8-14,17-18,29-30H,3-4,6-7,15-16,19-20H2,1-2H3,(H,42,43,49);3-5,7-8,10-12,15-16,27-28H,6,9,13-14,17-18H2,1-2H3,(H,40,41,47)/t24?,34-,36?,37+,41-;29-,30+,37-;27-,28+,35-/m000/s1
InChIKeyAODRLDFKVFNICO-YZCOWMKUSA-N
XLogP16.24
TPSA427.42 Ų
H-Bond Donors2
H-Bond Acceptors30
Rotatable Bonds14
Heavy Atoms150
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002148.10
LogP ≤ 516.24
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US11001600, Cmp No. 33
CID 126622254
US11053253, Cmp No. T-87
CID 156566770
US11053253, Cmp No. T-77
CID 162678202
US11084800, Cpd No. 70
CID 135317563
US11084800, Cpd No. 449
CID 135317872
US11084800, Cpd No. 29
CID 135318165
US11084800, Cpd No. 166
CID 135318286
US11084800, Cpd No. 152
CID 135318777
US11084800, Cpd No. 134
CID 135319186
US11084800, Cpd No. 114
CID 142420399
US11084800, Cpd No. 32
CID 142420451
US11053253, Cmp No. T-141
CID 147046405

Frequently Asked Questions

What is the IUPAC name of (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one?
The IUPAC name of (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one (CID 157177253) is (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one.
What is the SMILES notation for (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one?
The canonical SMILES for (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one is CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]4(COc5cccc(n5)CCCCc5ccc(Br)nc5NC3=O)C[C@@H]24)c2ccc(-c3cnc(C)nc3)cc12.CC(=O)c1nn(CC(=O)N2[C@H]3C[C@@]4(COc5cccc(n5)CCc5ccc(Br)nc5NC3=O)C[C@@H]24)c2ccc(-c3cnc(C)nc3)cc12.COC1CCC(=O)CC[C@@]23C[C@@H](C(=O)Cc4cccc(C)n4)N(C(=O)Cn4nc(C(C)=O)c5cc(-c6cnc(C)nc6)cc(c54)CCCC1C)[C@@H]2C3.
What is the InChIKey of (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one?
The InChIKey is AODRLDFKVFNICO-YZCOWMKUSA-N. The full InChI is InChI=1S/C41H48N6O5.C37H35BrN8O4.C35H31BrN8O4/c1-24-8-6-10-28-16-29(30-21-42-27(4)43-22-30)17-33-39(26(3)48)45-46(40(28)33)23-38(51)47-34(35(50)18-31-11-7-9-25(2)44-31)19-41(20-37(41)47)15-14-32(49)12-13-36(24)52-5;1-21(47)34-27-14-24(25-17-39-22(2)40-18-25)10-12-28(27)45(44-34)19-33(48)46-29-15-37(16-30(37)46)20-50-32-9-5-8-26(41-32)7-4-3-6-23-11-13-31(38)42-35(23)43-36(29)49;1-19(45)32-25-12-22(23-15-37-20(2)38-16-23)7-10-26(25)43(42-32)17-31(46)44-27-13-35(14-28(35)44)18-48-30-5-3-4-24(39-30)9-6-21-8-11-29(36)40-33(21)41-34(27)47/h7,9,11,16-17,21-22,24,34,36-37H,6,8,10,12-15,18-20,23H2,1-5H3;5,8-14,17-18,29-30H,3-4,6-7,15-16,19-20H2,1-2H3,(H,42,43,49);3-5,7-8,10-12,15-16,27-28H,6,9,13-14,17-18H2,1-2H3,(H,40,41,47)/t24?,34-,36?,37+,41-;29-,30+,37-;27-,28+,35-/m000/s1.
What are the key properties of (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one?
(1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one has a molecular weight of 2148.10 g/mol, XLogP of 16.24, 14 rotatable bonds, 2 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,23R,26S)-17-acetyl-7-methoxy-8-methyl-26-[2-(6-methyl-2-pyridinyl)acetyl]-14-(2-methylpyrimidin-5-yl)-18,19,22-triazapentacyclo[20.2.2.112,16.01,23.019,27]heptacosa-12(27),13,15,17-tetraene-4,21-dione;(1S,21S,23R)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-16-bromo-3-oxa-17,19,22,26-tetrazapentacyclo[19.3.1.14,8.01,23.013,18]hexacosa-4,6,8(26),13(18),14,16-hexaen-20-one;(1S,19S,21R)-20-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-14-bromo-3-oxa-15,17,20,24-tetrazapentacyclo[17.3.1.14,8.01,21.011,16]tetracosa-4,6,8(24),11(16),12,14-hexaen-18-one is sourced from PubChem (CID 157177253), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).